ARK Investment Management - NURIX THERAPEUTICS INC ownership

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 122 filers reported holding NURIX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of NURIX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,381,349
-9.8%
2,593,047
+14.7%
0.16%
+4.0%
Q2 2023$22,588,099
+13.6%
2,261,071
+0.9%
0.15%
+9.5%
Q1 2023$19,889,948
-8.9%
2,239,859
+12.7%
0.14%
-27.5%
Q4 2022$21,831,029
+30.2%
1,988,254
+54.5%
0.19%
+61.5%
Q3 2022$16,763,000
+113.4%
1,286,522
+65.2%
0.12%
+154.3%
Q2 2022$7,857,000
+43.1%
778,725
+98.7%
0.05%
+100.0%
Q1 2022$5,492,000
+331.8%
391,991
+792.0%
0.02%
+475.0%
Q4 2021$1,272,00043,9470.00%
Other shareholders
NURIX THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,822,883$14,327,8601.60%
DAFNA Capital Management LLC 556,695$4,375,6231.36%
Redmile Group, LLC 2,848,827$22,391,7801.06%
Deep Track Capital, LP 2,997,830$23,562,9440.91%
WestHill Financial Advisors, Inc. 283,333$2,226,9970.65%
Soleus Capital Management, L.P. 814,000$6,398,0400.59%
Affinity Asset Advisors, LLC 250,000$1,965,0000.55%
Boxer Capital, LLC 1,224,892$9,627,6510.51%
AtonRa Partners 24,227$190,4240.40%
WASATCH ADVISORS LP 3,564,616$28,017,8820.18%
View complete list of NURIX THERAPEUTICS INC shareholders